MX2021013874A - Metodo para mejorar los sintomas del tracto urinario inferior. - Google Patents

Metodo para mejorar los sintomas del tracto urinario inferior.

Info

Publication number
MX2021013874A
MX2021013874A MX2021013874A MX2021013874A MX2021013874A MX 2021013874 A MX2021013874 A MX 2021013874A MX 2021013874 A MX2021013874 A MX 2021013874A MX 2021013874 A MX2021013874 A MX 2021013874A MX 2021013874 A MX2021013874 A MX 2021013874A
Authority
MX
Mexico
Prior art keywords
urinary tract
lower urinary
tract symptoms
improving lower
improving
Prior art date
Application number
MX2021013874A
Other languages
English (en)
Inventor
Paul Averback
Original Assignee
Nymox Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nymox Corp filed Critical Nymox Corp
Publication of MX2021013874A publication Critical patent/MX2021013874A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Las realizaciones incluyen métodos para mejorar los síntomas en mamíferos que tienen los Síntomas del Tracto Urinario Inferior (conocido como "LUTS" por sus siglas en inglés), usando composiciones que contienen Triflutato de Fexapotida y un vehículo farmacéuticamente aceptable. El método incluye, pero no se limita a, administrar Triflutato de Fexapotida por vía intramuscular, oral, intravenosa, intratecal, intratumoral, intranasal, tópica, transdérmica, etc., ya sea solo o con un portador a un mamífero que lo necesite.
MX2021013874A 2019-05-13 2020-05-06 Metodo para mejorar los sintomas del tracto urinario inferior. MX2021013874A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/410,685 US20200360466A1 (en) 2019-05-13 2019-05-13 Method of improving lower urinary tract symptoms
PCT/US2020/031592 WO2020231690A1 (en) 2019-05-13 2020-05-06 Method of improving lower urinary tract symptoms

Publications (1)

Publication Number Publication Date
MX2021013874A true MX2021013874A (es) 2022-02-21

Family

ID=70775600

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021013874A MX2021013874A (es) 2019-05-13 2020-05-06 Metodo para mejorar los sintomas del tracto urinario inferior.

Country Status (11)

Country Link
US (1) US20200360466A1 (es)
EP (1) EP3969029A1 (es)
JP (1) JP2022532314A (es)
KR (1) KR20220008303A (es)
CN (1) CN114206370A (es)
AU (1) AU2020274312A1 (es)
BR (1) BR112021022688A2 (es)
CA (1) CA3139959A1 (es)
IL (1) IL287924A (es)
MX (1) MX2021013874A (es)
WO (1) WO2020231690A1 (es)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4457489A (en) 1981-07-13 1984-07-03 Gilmore Samuel E Subsea fluid conduit connections for remote controlled valves
US6924266B2 (en) 2001-05-25 2005-08-02 Nymox Corporation NTP-peptides and method for removal of tumors
ES2281529T3 (es) 2001-07-19 2007-10-01 Nymox Corporation Peptidos eficaces en el tratamiento de tumores y otras afecciones que requieren la eliminacion o destruccion de celulas.
US7317077B2 (en) 2001-11-16 2008-01-08 Nymox Pharmaceutical Corporation Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
EA200801853A1 (ru) 2006-02-28 2009-02-27 Наймокс Корпорейшн Пептиды, эффективные в лечении опухолей и других заболеваний, требующих удаления или разрушения клеток
US20160215031A1 (en) 2015-01-27 2016-07-28 Nymox Pharnaceutical Corporation Method of treating disorders requiring destruction or removal of cells
US20160361380A1 (en) 2015-06-12 2016-12-15 Nymox Corporation Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations
US11628202B2 (en) 2015-07-24 2023-04-18 Nymox Corporation Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia
US10183058B2 (en) 2016-06-17 2019-01-22 Nymox Corporation Method of preventing or reducing the progression of prostate cancer
US10532081B2 (en) * 2016-09-07 2020-01-14 Nymox Corporation Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
US10335453B2 (en) * 2017-03-01 2019-07-02 Nymox Corporation Compositions and methods for improving sexual function

Also Published As

Publication number Publication date
KR20220008303A (ko) 2022-01-20
AU2020274312A1 (en) 2021-12-02
US20200360466A1 (en) 2020-11-19
CA3139959A1 (en) 2020-11-19
EP3969029A1 (en) 2022-03-23
JP2022532314A (ja) 2022-07-14
IL287924A (en) 2022-01-01
WO2020231690A1 (en) 2020-11-19
BR112021022688A2 (pt) 2021-12-28
CN114206370A (zh) 2022-03-18

Similar Documents

Publication Publication Date Title
EP4275688A3 (en) Method of ameliorating or preventing the worsening or the progression of symptoms of bph
MX2018012564A (es) Peptido de la cadena neural para prevenir o reducir el avance de cancer de prostata.
WO2001085154A8 (en) Method of treating immune pathologies with low dose estrogen
MXPA05004110A (es) Composiciones y metodos para terapia de oxibutinina transdermica.
IL140272A0 (en) Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
PH12018500023A1 (en) Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
MX342305B (es) Minimizacion de experiencias adversas asociadas con la terapia con oxibutinina.
MX2019010394A (es) Composiciones y metodos para mejorar la funcion sexual.
WO2007047194A3 (en) Methods for treating mitf-related disorders
RU2016151738A (ru) Мезенхимальные стромальные клетки для лечения синдрома системной воспалительной реакции
GEP20227396B (en) Compounds and their uses for alleviating menopause-associated symptoms
MX2021013874A (es) Metodo para mejorar los sintomas del tracto urinario inferior.
EP4252777A3 (en) High concentration anti-ass protofibril antibody formulations and methods of use thereof
MX2019001209A (es) Metodo para evitar o reducir la incidencia de la retencion urinaria aguda.
WO2019204332A3 (en) Pak4 inhibitors and methods of use
MX2020008703A (es) Metodo de tratamiento de la hiperlasia prostatica benigna con antibioticos.
DE50311092D1 (de) Cerebrale protektion mit einem xenonhaltigen gas
MX2022001274A (es) Agente serotoninergico y antagonista del receptor 5-ht1a.
WO2020226986A3 (en) Methods of treating cancer with an anti-pd-l1 antibody
WO2021067611A3 (en) Compositions and methods for treating alzheimer's disease
Hui Study on the Operation Mode of Library Makerspace with Public Participation
CN204916792U (zh) 一种有利于提高垃圾压缩比的厢体
CN205534678U (zh) 一种膨胀管
JP1717361S (ja) 充電器
TWD209678S (zh) 充電器之電氣介接部